ZCT Stock Overview

A technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. More details

ZCT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Highly volatile share price over the past 3 months compared to the Canadian market

Has not reported any financial data

Does not have a meaningful market cap (CA$9M)

My Notes

Capture your thoughts, links and company narrative

Zero Candida Technologies, Inc. Competitors

Therma Bright

TSXV:THRM

CA$18.1m

Scryb

CNSX:SCYB

CA$4.8m

ASEP Medical Holdings

CNSX:ASEP

CA$3.8m

Aurora Spine

TSXV:ASG

CA$28.3m

Price History & Performance

Summary of share price highs, lows and changes for Zero Candida Technologies
Historical stock prices
Current Share Price	CA$0.45
52 Week High	CA$2.13
52 Week Low	CA$0.36
Beta	0
1 Month Change	-18.18%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-78.87%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	ZCT	CA Medical Equipment	CA Market
7D	12.5%	-3.9%	0.1%
1Y	n/a	-18.3%	19.1%

Return vs Industry: Insufficient data to determine how ZCT performed against the Canadian Medical Equipment industry.

Return vs Market: Insufficient data to determine how ZCT performed against the Canadian Market.

Price Volatility

Is ZCT's price volatile compared to industry and market?
ZCT volatility
ZCT Average Weekly Movement	25.6%
Medical Equipment Industry Average Movement	13.2%
Market Average Movement	8.6%
10% most volatile stocks in CA Market	18.1%
10% least volatile stocks in CA Market	3.0%

Stable Share Price: ZCT's share price has been volatile over the past 3 months compared to the Canadian market.

Volatility Over Time: Insufficient data to determine ZCT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	n/a	www.zero-candida.com

Zero Candida Technologies, Inc., a technology company, designs, develops, manufactures, and sells non-drug blue light therapy devices for the treatment of vulvo-vaginal candidiasis. It offers Zero Candida, a smart vaginal diagnostic device that collects and transmits treatment data to the attending physician in real time for assessment, treatment, personalization, and monitoring. The company is headquartered in Vancouver, Canada.

Zero Candida Technologies, Inc. Fundamentals Summary

How do Zero Candida Technologies's earnings and revenue compare to its market cap?
ZCT fundamental statistics
Market cap	CA$9.18m
Earnings (TTM)	CA$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is ZCT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ZCT income statement (TTM)
Revenue	CA$0
Cost of Revenue	CA$0
Gross Profit	CA$0
Other Expenses	CA$0
Earnings	CA$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did ZCT perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/12 04:56
End of Day Share Price	2025/02/12 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Zero Candida Technologies, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.